Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine

Objectives Acute necrotizing encephalopathy (ANE) is a rare neurological disorder arising from a para- or post-infectious “cytokine storm. ”It has recently been reported in association with coronavirus disease 2019 (COVID-19) infection. Methods A 56-year-old male with a diagnosis of ANE 48 h following the first dose of ChAdOx1 nCoV-19 vaccination was investigated. Cytokine analyses on serum and cerebrospinal fluid (CSF) were performed. The patient was treated with high-dose corticosteroids and followed clinically and radiologically. Results Favorable clinical and radiological outcomes were noted. There was an upregulation in serum levels of CXCL5, CXCL1, Il-8, IL-15, CCL2, TGF-B, and EGF, and up-regulation in CSF levels of CXCL5, IL-2, IL-3, and IL-8. Discussion As COVID-19 infection has been previously reported as a possible rare cause of ANE, we speculate on an aberrant immune response mechanism that was brought about by the vaccine. To increase our understanding of the pathogenesis of ANE in the context of COVID-19 vaccination and to better define its clinical features and outcomes, clinicians and scientists should continue reporting convincing cases of such entities.

[1]  I. Kumar,et al.  Rapidly Progressive Dementia with Asymmetric Rigidity Following ChAdOx1 nCoV-19 Vaccination , 2022, Aging and disease.

[2]  Boby Varkey Maramattom,et al.  Central nervous system adverse events after ChAdOx1 vaccination , 2022, Neurological Sciences.

[3]  K. Buzzard,et al.  Acute haemorrhagic necrotizing encephalopathy in the setting of SARS-CoV-2 vaccination: a case report and literature review , 2022, Acta Neurologica Belgica.

[4]  Jainn-Jim Lin,et al.  Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing Encephalopathy , 2022, Children.

[5]  M. Mühlau,et al.  Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination , 2022, Frontiers in Neurology.

[6]  Taewon Kim,et al.  Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination , 2021, Neurological Sciences.

[7]  Stephanie Lau,et al.  Acute disseminated encephalomyelitis (ADEM) following recent Oxford/AstraZeneca COVID-19 vaccination , 2021, Forensic Science, Medicine and Pathology.

[8]  R. Klingebiel,et al.  Postvaccinal Encephalitis after ChAdOx1 nCov‐19 , 2021, Annals of neurology.

[9]  S. Kushner,et al.  Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models , 2021, mSphere.

[10]  S. Wen,et al.  COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2 , 2021, Journal of Neurology.

[11]  M. Palmer,et al.  CSF , 2020, Encyclopedia of Autism Spectrum Disorders.

[12]  Nguyen H. Tran,et al.  T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial , 2020, Nature Medicine.

[13]  Subhash Kumar,et al.  Acute Necrotizing Encephalitis as a Probable Association of COVID-19 , 2020, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[14]  S. Marsch,et al.  Acute Hemorrhagic Leukoencephalitis: A Case and Systematic Review of the Literature , 2020, Frontiers in Neurology.

[15]  J. Benito-León,et al.  Bilateral thalamic changes in anti-NMDAR encephalitis presenting with hemichorea and dystonia and acute transient psychotic disorder , 2020, Journal of Neuroimmunology.

[16]  Nguyen H. Tran,et al.  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial , 2020, The Lancet.

[17]  B. Knebelmann,et al.  Case report and literature review , 2016, Medicine.

[18]  Pierre-Luc Gamache,et al.  Pulvinar sign in a case of anti-HU paraneoplastic encephalitis , 2016, The neuroradiology journal.

[19]  K. Kothur,et al.  CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review. , 2016, Cytokine.

[20]  Kangding Liu,et al.  Acute Necrotizing Encephalopathy: An Underrecognized Clinicoradiologic Disorder , 2015, Mediators of inflammation.

[21]  D. Karussis,et al.  The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. , 2014, Autoimmunity reviews.

[22]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[23]  Sheng-Kwei Song,et al.  Neuropathologic correlates for diffusion tensor imaging in postinfectious encephalopathy. , 2011, Pediatric neurology.

[24]  A. Agildere,et al.  Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination: diffusion-weighted imaging and proton MR spectroscopy findings , 2010, Pediatric Radiology.

[25]  C. Navarro,et al.  Acute necrotizing encephalopathy of childhood: report of a Spanish case. , 2007, Pediatric neurology.

[26]  N. Bessis,et al.  Immune responses to gene therapy vectors: influence on vector function and effector mechanisms , 2004, Gene therapy.

[27]  Munhyang Lee,et al.  Acute Necrotizing Encephalopathy in Korean Infants and Children: Imaging Findings and Diverse Clinical Outcome , 2004, Korean Journal of Radiology.

[28]  T. Ichiyama,et al.  Serum cytokine concentrations of influenza‐associated acute necrotizing encephalopathy , 2003, Pediatrics international : official journal of the Japan Pediatric Society.

[29]  Toru Watanabe,et al.  Study of Influenza-Associated Encephalitis/Encephalopathy in Children During the 1997 to 2001 Influenza Seasons , 2001, Journal of child neurology.

[30]  M. Mizuguchi.  Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan , 1997, Brain and Development.

[31]  A. Davies,et al.  Immune Responses , 1971, Nature.